scholarly article | Q13442814 |
P8978 | DBLP publication ID | journals/jcisd/CuzzolinSDSSCM16 |
P356 | DOI | 10.1021/ACS.JCIM.5B00702 |
P698 | PubMed publication ID | 27019343 |
P50 | author | Stefano Moro | Q37828926 |
Antonella Ciancetta | Q45340085 | ||
Davide Sabbadin | Q46216415 | ||
Mattia Sturlese | Q50731869 | ||
Giuseppe Deganutti | Q57086103 | ||
Veronica Salmaso | Q57116999 | ||
P2093 | author name string | Alberto Cuzzolin | |
P433 | issue | 4 | |
P304 | page(s) | 687-705 | |
P577 | publication date | 2016-03-28 | |
P1433 | published in | Journal of Chemical Information and Modeling | Q3007982 |
P1476 | title | Deciphering the Complexity of Ligand-Protein Recognition Pathways Using Supervised Molecular Dynamics (SuMD) Simulations. | |
P478 | volume | 56 |
Q47189947 | ART-RRT: As-Rigid-As-Possible exploration of ligand unbinding pathways |
Q47342876 | AquaMMapS: an alternative tool to monitor the role of water molecules during protein-ligand association. |
Q58719254 | Bridging Molecular Docking to Molecular Dynamics in Exploring Ligand-Protein Recognition Process: An Overview |
Q48127796 | Comparison of the Human A2A Adenosine Receptor Recognition by Adenosine and Inosine: New Insight from Supervised Molecular Dynamics Simulations |
Q93166611 | Coupling Supervised Molecular Dynamics (SuMD) with Entropy Estimations To Shine Light on the Stability of Multiple Binding Sites |
Q47374327 | Dynamic Docking: A Paradigm Shift in Computational Drug Discovery |
Q38737287 | Estimation of kinetic and thermodynamic ligand-binding parameters using computational strategies |
Q90347731 | Exploring the RNA-Recognition Mechanism Using Supervised Molecular Dynamics (SuMD) Simulations: Toward a Rational Design for Ribonucleic-Targeting Molecules? |
Q47225761 | Impact of protein-ligand solvation and desolvation on transition state thermodynamic properties of adenosine A2A ligand binding kinetics |
Q90700664 | Molecular Signature for Receptor Engagement in the Metabolic Peptide Hormone Amylin |
Q93202753 | Prospects of multitarget drug designing strategies by linking molecular docking and molecular dynamics to explore the protein-ligand recognition process |
Q92485727 | Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines to develop functionalized ligands to target adenosine receptors: fluorescent ligands as an example |
Q90441685 | Reconstruction of apo A2A receptor activation pathways reveal ligand-competent intermediates and state-dependent cholesterol hotspots |
Q92290741 | Revisiting the Allosteric Regulation of Sodium Cation on the Binding of Adenosine at the Human A2A Adenosine Receptor: Insights from Supervised Molecular Dynamics (SuMD) Simulations |
Q38911603 | Structural Probing and Molecular Modeling of the A₃ Adenosine Receptor: A Focus on Agonist Binding |
Q98564759 | Structure and dynamics of the active Gs-coupled human secretin receptor |
Q50641788 | Supporting the Identification of Novel Fragment-Based Positive Allosteric Modulators Using a Supervised Molecular Dynamics Approach: A Retrospective Analysis Considering the Human A2A Adenosine Receptor as a Key Example. |
Q47324899 | Synthesis and preliminary structure-activity relationship study of 2-aryl-2H-pyrazolo[4,3-c]quinolin-3-ones as potential checkpoint kinase 1 (Chk1) inhibitors |
Q57785102 | Targeting protein kinase CK1δ with Riluzole: could it be one of the possible missing bricks to interpret its effect in the treatment of ALS from a molecular point of view? |
Q103826033 | Targeting the coronavirus SARS-CoV-2: computational insights into the mechanism of action of the protease inhibitors lopinavir, ritonavir and nelfinavir |
Q91277335 | Tracking Hidden Binding Pockets Along the Molecular Recognition Path of l-Trp to Indoleamine 2,3-Dioxygenase 1 |
Search more.